180 Life Sciences Corp. (ATNF)
NASDAQ: ATNF · Real-Time Price · USD
0.8610
-0.0090 (-1.03%)
Apr 23, 2025, 4:00 PM EDT - Market closed

180 Life Sciences Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2018 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2018 - 2019
Selling, General & Admin
4.3610.6915.4711.693.36
Upgrade
Research & Development
1.972.782.433.952.29
Upgrade
Operating Expenses
6.3213.4817.915.645.65
Upgrade
Operating Income
-6.32-13.48-17.9-15.64-5.65
Upgrade
Interest Expense
-0.05-0.04-0.03-0.19-1.09
Upgrade
Interest & Investment Income
--0--
Upgrade
Other Non Operating Income (Expenses)
1.250.115.14-5.44-1.55
Upgrade
EBT Excluding Unusual Items
-5.13-13.43-2.78-21.26-8.29
Upgrade
Impairment of Goodwill
---33.55--
Upgrade
Gain (Loss) on Sale of Assets
-----0.04
Upgrade
Other Unusual Items
0.190.2-0.92-2.58
Upgrade
Pretax Income
-6.46-22.28-39.67-20.35-10.9
Upgrade
Income Tax Expense
-0.3-2.35-0.94-0.02-0.02
Upgrade
Net Income
-6.17-19.94-38.73-20.32-10.88
Upgrade
Preferred Dividends & Other Adjustments
8.01---1.12
Upgrade
Net Income to Common
-14.18-19.94-38.73-20.32-12.01
Upgrade
Shares Outstanding (Basic)
10000
Upgrade
Shares Outstanding (Diluted)
10000
Upgrade
Shares Change (YoY)
141.47%279.01%21.22%72.72%64.51%
Upgrade
EPS (Basic)
-15.49-52.59-387.18-246.32-251.32
Upgrade
EPS (Diluted)
-15.49-52.59-387.18-246.32-251.32
Upgrade
Free Cash Flow
-1.48-10.92-12.13-19.37-3.87
Upgrade
Free Cash Flow Per Share
-1.62-28.81-121.25-234.76-81.05
Upgrade
EBITDA
-6.27-13.37-17.79-15.53-5.52
Upgrade
D&A For EBITDA
0.060.110.110.110.13
Upgrade
EBIT
-6.32-13.48-17.9-15.64-5.65
Upgrade
Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q